ClinicalTrials.gg
Status unknownNCT01630954Updated Mar 23, 2016

A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform Mole

A Phase 4 interventional study of Suction and evacuation and Suction and evacuation in Hydatidiform Mole, sponsored by Nilratan Sircar Medical College. Status unknown at 1 site in India. Open to female participants aged 15 Years to 45 Years. Per ClinicalTrials.gov, last updated 2016-03-23.

Sponsored by Nilratan Sircar Medical College · Phase 4, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Mar 2016), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 4
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
15 Years to 45 Years
Sex
Female
01

Study summary

Hydatidiform mole is a common complication of pregnancy with an incidence of 1in 400 pregnancies in India. Although this is a benign condition , it is having the malignant potential too. A repeat curettage after evacuation of hydatidiform mole was generally advocated till 1990s. A thorough curettage at the time of initial evacuation was not performed because of larger size of uterus and risk of perforation. Subsequently a number of studies assessed the usefulness of repeat curettage and found it was unnecessary and not cost effective . However all these studies are retrospective in design and conducted in developed countries where hydatidiform mole is diagnosed earlier because of wider use of ultrasonography. Thus there is a need to perform a well designed prospective study to compare the effectiveness of single evacuation with double evacuation in treatment of hydatidiform mole for prevention of Gestational Trophoblastic Neoplasia.This study compares the effectiveness of single evacuation versus double evacuation for treatment of hydatidiform mole for prevention of gestational trophoblastic neoplasia .

02

Conditions studied

  • Hydatidiform Mole

Keywords

  • Hydatidiform mole
  • Molar pregnancy
  • H Mole
  • GTN
  • GTD
03

In context

Lead sponsor

Nilratan Sircar Medical College is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Ultrasound confirmed complete mole

Exclusion criteria

Exclusion Criteria:

  • Partial mole
  • History of treatment for molar pregnancy like prior evacuation or chemotherapy
  • Women requiring hysterectomy for treatment of H Mole
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Active comparator
    Single evacuation of mole,

    Procedure: Suction and evacuation

  • Active comparator
    Double evacuation of mole

    Procedure: Suction and evacuation

Interventions

  • ProcedureSuction and evacuation

    In single evacuation group women will be treated by suction evacuation and curettage is performed at the end of evacuation in one sitting. An ultrasound will be done later to examine completeness of evacuation. If there is significant amount of residual molar tissue or persistence of heavy bleeding a repeat curettage will be done . Women will be followed up with serum beta hcg 1 week after the evacuation and then weekly till the titer is negative. After three consecutive negative titre beat HCG estimation will be done at two weekly interval.

    Also known as: Suction curettage

  • ProcedureSuction and evacuation

    In double evacuation group , women will be treated by suction evacuation and a thorough curettage will be avoided. A second evacuation with thorough curettage will be performed after 5 - 7 days of first evacuation.

    Also known as: Suction curettage

06

What researchers measure

Primary outcomes

  1. Proportion of patents diagnosed as GTN following treatment in each group

    Time frame: Six months following evacuation

Secondary outcomes

  1. Maternal complications,

    Time frame: Six months

  2. Time interval of normalization of HCG

    Time frame: Six months following evacuation

  3. Duration of hospital stay

    Time frame: Two weeks following admission

07

Study locations

1 of 1 sites recruiting
  • Dr Snehamay Chaudhuri
    Kolkata, West Bengal 700010, India
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jun 2012, a primary completion of Dec 2018 and a completion of Jun 2019. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 24, 2012
First posted
Jun 28, 2012
Start
Jun 2012
Primary completionEst.
Dec 2018
CompletionEst.
Jun 2019
Last update
Mar 23, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 23, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01630954
Lead sponsor
Nilratan Sircar Medical College
Responsible party
Dr Snehamay Chaudhuri (Associate Professor,Obstetrics and Gynecology, NRS Medical College, Nilratan Sircar Medical College) — Principal investigator
First posted
Jun 28, 2012
Start date
Jun 2012
Primary completion
Dec 2018 (estimated)
Completion
Jun 2019 (estimated)
Last update
Mar 23, 2016

Study contacts

Snehamay Chaudhuri, MD, DNB
Contact
snehamay_chaudhuri_dr@yahoo.com
091-33-23537900
Snehamay Chaudhuri, MD, DNB
principal investigator · Associate Professor, Obstetrics and Gynecology, NRS Medical College , Kolkata,India

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion